Crescita Therapeutics (CTX) Stock Chart & Stock Price History → The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad) Free CTX Stock Alerts C$0.43 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Crescita Therapeutics Stock Price Performance5 Day Performance-1.15%1 Month Performance-4.44%3 Month Performance-20.37%6 Month Performance-32.81%Year-To-Date Performance-12.24%1 Year Performance-34.85% Receive CTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. CTX Stock Chart for Friday, April, 26, 2024 CTX Chart by TradingView Crescita Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024C$0.44C$0.43-2.27%C$0.44C$0.434,515 shsC$8.40 million04/24/2024C$0.44C$0.44C$0.44C$0.444,000 shsC$8.60 million04/23/2024C$0.43C$0.44+2.33%C$0.44C$0.433,500 shsC$8.60 million04/22/2024C$0.44C$0.43-1.15%C$0.44C$0.434,700 shsC$8.40 million04/19/2024C$0.44C$0.44C$0.44C$0.443,761 shsC$8.50 million04/18/2024C$0.42C$0.44+3.57%C$0.44C$0.433,000 shsC$8.50 million Get the Latest News and Ratings for CTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024C$0.42C$0.42C$0.42C$0.421,173 shsC$8.21 million04/15/2024C$0.42C$0.42C$0.42C$0.4223,000 shsC$8.21 million04/12/2024C$0.42C$0.42C$0.42C$0.4223,000 shsC$8.21 million04/11/2024C$0.42C$0.42C$0.42C$0.4223,000 shsC$8.21 million04/10/2024C$0.44C$0.42-4.55%C$0.42C$0.4212,500 shsC$8.21 million04/09/2024C$0.46C$0.44-3.30%C$0.46C$0.4412,950 shsC$8.60 million04/08/2024C$0.44C$0.46+3.41%C$0.46C$0.46561 shsC$8.89 million04/05/2024C$0.44C$0.44C$0.45C$0.4428,500 shsC$8.60 million04/04/2024C$0.44C$0.44C$0.45C$0.4428,500 shsC$8.60 million04/03/2024C$0.43C$0.44+2.33%C$0.44C$0.445,300 shsC$8.60 million04/02/2024C$0.45C$0.43-4.44%C$0.45C$0.4319,500 shsC$8.40 million03/28/2024C$0.45C$0.45C$0.45C$0.453,500 shsC$8.79 million03/27/2024C$0.45C$0.45C$0.45C$0.453,500 shsC$8.79 million03/26/2024C$0.43C$0.45+4.65%C$0.45C$0.4515,500 shsC$8.79 million03/25/2024C$0.40C$0.43+7.50%C$0.49C$0.4162,000 shsC$8.40 million03/22/2024C$0.40C$0.40C$0.40C$0.407,000 shsC$7.82 million03/21/2024C$0.39C$0.40+2.56%C$0.40C$0.3826,000 shsC$8.00 million03/20/2024C$0.40C$0.39-1.27%C$0.39C$0.396,500 shsC$7.80 million03/19/2024C$0.40C$0.40-1.25%C$0.40C$0.401,661 shsC$7.90 million03/18/2024C$0.39C$0.40+2.56%C$0.42C$0.405,090 shsC$8.00 million03/15/2024C$0.37C$0.39+6.85%C$0.39C$0.3626,000 shsC$7.80 million03/14/2024C$0.38C$0.37-2.67%C$0.37C$0.3627,500 shsC$7.30 million03/13/2024C$0.38C$0.38C$0.38C$0.3712,000 shsC$7.50 million03/12/2024C$0.38C$0.38-1.32%C$0.38C$0.3712,000 shsC$7.50 million03/11/2024C$0.39C$0.38-1.30%C$0.40C$0.3833,000 shsC$7.60 million03/08/2024C$0.39C$0.39-1.28%C$0.42C$0.3913,200 shsC$7.70 million03/07/2024C$0.39C$0.39+1.30%C$0.40C$0.3968,684 shsC$7.80 million03/06/2024C$0.40C$0.39-3.75%C$0.40C$0.394,000 shsC$7.70 million03/05/2024C$0.40C$0.40C$0.42C$0.40111,590 shsC$8.00 million03/04/2024C$0.40C$0.40C$0.40C$0.4019,500 shsC$8.00 million03/01/2024C$0.40C$0.40C$0.42C$0.4055,000 shsC$8.00 million02/29/2024C$0.42C$0.40-4.76%C$0.42C$0.4055,000 shsC$8.00 million02/28/2024C$0.43C$0.42-2.33%C$0.43C$0.4231,500 shsC$8.40 million02/27/2024C$0.44C$0.43-2.27%C$0.44C$0.4310,050 shsC$8.60 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.02/26/2024C$0.44C$0.44C$0.44C$0.44500 shsC$8.80 million02/23/2024C$0.44C$0.44C$0.44C$0.44500 shsC$8.80 million02/22/2024C$0.45C$0.44-2.22%C$0.45C$0.448,800 shsC$8.80 million02/21/2024C$0.44C$0.45+2.27%C$0.45C$0.451,000 shsC$9.00 million02/20/2024C$0.46C$0.44-4.35%C$0.44C$0.445,500 shsC$8.80 million02/19/2024C$0.46C$0.46C$0.50C$0.4462,361 shsC$9.20 million02/16/2024C$0.46C$0.46C$0.50C$0.4462,361 shsC$9.20 million02/15/2024C$0.48C$0.46-4.17%C$0.50C$0.4462,361 shsC$9.20 million02/14/2024C$0.48C$0.48C$0.48C$0.482,000 shsC$9.60 million02/13/2024C$0.48C$0.48C$0.49C$0.484,500 shsC$9.60 million02/12/2024C$0.48C$0.48C$0.49C$0.484,000 shsC$9.60 million02/09/2024C$0.48C$0.48C$0.49C$0.484,000 shsC$9.60 million02/08/2024C$0.48C$0.48C$0.48C$0.481,500 shsC$9.60 million02/07/2024C$0.48C$0.48C$0.48C$0.484,250 shsC$9.60 million02/06/2024C$0.47C$0.48+2.13%C$0.48C$0.484,250 shsC$9.60 million02/05/2024C$0.47C$0.47C$0.50C$0.4719,500 shsC$9.40 million02/02/2024C$0.50C$0.47-6.00%C$0.50C$0.4719,500 shsC$9.40 million02/01/2024C$0.50C$0.50C$0.50C$0.505,010 shsC$10.00 million01/31/2024C$0.50C$0.50C$0.50C$0.503,510 shsC$10.00 million01/30/2024C$0.50C$0.50C$0.50C$0.504,000 shsC$10.00 million01/29/2024C$0.54C$0.50-7.41%C$0.50C$0.4424,000 shsC$10.00 million01/26/2024C$0.54C$0.54C$0.54C$0.545,500 shsC$10.80 million01/25/2024C$0.54C$0.54C$0.54C$0.5423,000 shsC$10.80 million Related Companies: VM Stock Price Chart MPH Stock Price Chart VPH Stock Price Chart WLLW Stock Price Chart DN Stock Price Chart NDVA Stock Price Chart ENTG Stock Price Chart LABS Stock Price Chart TMD Stock Price Chart QPT Stock Price Chart Receive CTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Crescita Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:CTX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescita Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.